Iranian Journal of Radiology

Published by: Kowsar

PI-RADS v2 in Prostate Cancer and Correlation with T Staging, PSA Levels and ADC Values

Kunwarpal Singh 1 , * , Kamlesh Gupta 1 , C. L. Thukral 1 , Priya Goyal 1 , Vijinder Arora 2 and Inderbir Singh 2
Authors Information
1 Department of Radiodiagnosis and Imaging, Sri Guru Ram Das Institute of Medical Sciences and Research, Vallah, Sri Amritsar, Baba Farid University of Health Sciences, Faridkot, India
2 Department of MRI, NIJJER SCAN and Diagnostic Centre, Amritsar, India
Article information
  • Iranian Journal of Radiology: January 2018, 15 (1); e14038
  • Published Online: December 23, 2017
  • Article Type: Research Article
  • Received: April 10, 2017
  • Revised: October 21, 2017
  • Accepted: November 4, 2017
  • DOI: 10.5812/iranjradiol.14038

To Cite: Singh K, Gupta K, Thukral C L, Goyal P, Arora V, et al. PI-RADS v2 in Prostate Cancer and Correlation with T Staging, PSA Levels and ADC Values, Iran J Radiol. 2018 ; 15(1):e14038. doi: 10.5812/iranjradiol.14038.

Abstract
Copyright © 2017, Iranian Journal of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Futterer JJ, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, et al. Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. Eur Urol. 2015;68(6):1045-53. doi: 10.1016/j.eururo.2015.01.013. [PubMed: 25656808].
  • 2. Heidenreich A. Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. Eur Urol. 2011;59(4):495-7. doi: 10.1016/j.eururo.2011.01.013. [PubMed: 21256671].
  • 3. Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, et al. Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol. 2016;69(1):41-9. doi: 10.1016/j.eururo.2015.08.038. [PubMed: 26361169].
  • 4. Hassanzadeh E, Glazer DI, Dunne RM, Fennessy FM, Harisinghani MG, Tempany CM. Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review. Abdom Radiol (NY). 2017;42(1):278-89. doi: 10.1007/s00261-016-0871-z. [PubMed: 27522352].
  • 5. Durmus T, Baur A, Hamm B. Multiparametric magnetic resonance imaging in the detection of prostate cancer. Aktuelle Urol. 2014;45(2):119-26. doi: 10.1055/s-0034-1371875. [PubMed: 24700068].
  • 6. Hoeks CM, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SW, et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology. 2011;261(1):46-66. doi: 10.1148/radiol.11091822. [PubMed: 21931141].
  • 7. Villeirs GM, Oosterlinck W, Vanherreweghe E, De Meerleer GO. A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer. Eur J Radiol. 2010;73(2):352-6. doi: 10.1016/j.ejrad.2008.10.034. [PubMed: 19084363].
  • 8. Afifi AH, Ramadan AA, Alabbady A, Khalifa MHA. Multi-parametric MRI and PI-RADS (V1) scoring system: New inception in cancer prostate diagnosis to evaluate diagnostic performance of different score combinations. Egypt J Radiol Nuclear Med. 2016;47(3):1083-94. doi: 10.1016/j.ejrnm.2016.04.015.
  • 9. Somford DM, Hoeks CM, Hulsbergen-van de Kaa CA, Hambrock T, Futterer JJ, Witjes JA, et al. Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer. Invest Radiol. 2013;48(3):152-7. doi: 10.1097/RLI.0b013e31827b711e. [PubMed: 23328910].
  • 10. Hamoen EHJ, de Rooij M, Witjes JA, Barentsz JO, Rovers MM. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. Eur Urol. 2015;67(6):1112-21. doi: 10.1016/j.eururo.2014.10.033. [PubMed: 25466942].
  • 11. Platzek I, Borkowetz A, Toma M, Brauer T, Meissner C, Dietel K, et al. Multiparametric Prostate Magnetic Resonance Imaging at 3 T: Failure of Magnetic Resonance Spectroscopy to Provide Added Value. J Comput Assist Tomogr. 2015;39(5):674-80. doi: 10.1097/RCT.0000000000000261. [PubMed: 25938212].
  • 12. Tan CH, Hobbs BP, Wei W, Kundra V. Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol. 2015;204(4):W439-48. doi: 10.2214/AJR.14.13373. [PubMed: 25794093].
  • 13. Rosenkrantz AB, Oto A, Turkbey B, Westphalen AC. Prostate Imaging Reporting and Data System (PI-RADS), Version 2: A Critical Look. AJR Am J Roentgenol. 2016;206(6):1179-83. doi: 10.2214/AJR.15.15765. [PubMed: 26913638].
  • 14. Kasel-Seibert M, Lehmann T, Aschenbach R, Guettler FV, Abubrig M, Grimm MO, et al. Assessment of PI-RADS v2 for the Detection of Prostate Cancer. Eur J Radiol. 2016;85(4):726-31. doi: 10.1016/j.ejrad.2016.01.011. [PubMed: 26971415].
  • 15. Tewes S, Mokov N, Hartung D, Schick V, Peters I, et al. Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS)Version 1 and Version 2. PLoS One. 2016;11(9). doi: 10.1371/journal.pone.0162879.
  • 16. Alonzi R, Padhani AR. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol. 2007 9;63(3):335-50. doi: 10.1016/j.ejrad.2007.06.028. [PubMed: 17689907].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments